PHAT
NASDAQ · Pharmaceuticals
Phathom Pharmaceuticals Inc
$10.06
-0.51 (-4.83%)
Open$10.37
Previous Close$10.57
Day High$10.44
Day Low$10.00
52W High$18.31
52W Low$2.21
Volume—
Avg Volume863.6K
Market Cap937.97M
P/E Ratio—
EPS$-3.81
SectorPharmaceuticals
Analyst Ratings
Strong Buy
17 analysts
Price Target
+404.4% upside
Current
$10.06
$10.06
Target
$50.74
$50.74
$34.41
$50.74 avg
$70.04
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 70.96M | 173.93M | 162.51M |
| Net Income | -429,389,693 | 52.15M | 46.06M |
| Profit Margin | -605.1% | 30.0% | 28.4% |
| EBITDA | -355,349,993 | 99.13M | 88.44M |
| Free Cash Flow | — | 45.89M | 35.44M |
| Rev Growth | — | -4.6% | -5.1% |
| Debt/Equity | 1.24 | 0.67 | 0.68 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |